Effects of roflumilast in COPD patients receiving inhaled corticosteroid/long-acting β2-agonist fixed-dose combination: RE2SPOND rationale and study design

Stephen Rennard, Fernando Martinez, Klaus Rabe, Sanjay Sethi, Emilio Pizzichini, Andrew McIvor, Shahid Siddiqui, Antonio Anzueto, Haiyuan Zhu
  • International Journal of Chronic Obstructive Pulmonary Disease, August 2016, Dove Medical Press
  • DOI: 10.2147/copd.s109661

COPD exacerbation study design

The author haven't finished explaining this publicationThe author haven't finished explaining this publication

The following have contributed to this page: Dr. shahid siddiqui

In partnership with: